These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 20950840

  • 1. Monitoring treatments with unfractionated heparin: CTAD must be used instead of citrate as the anticoagulant solution when using partial-draw collection tubes. Results of a multicenter evaluation.
    Toulon P, Abecassis L, Smahi M, Ternisien C.
    Thromb Res; 2010 Dec; 126(6):536-42. PubMed ID: 20950840
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Underestimation of unfractionated heparin therapy assessment due to platelet activation when using partial-draw (pediatric) citrate collection tubes.
    Desconclois C, Eschwège V, Proulle V, Boutekedjiret T, Dreyfus M, Toulon P.
    Thromb Res; 2014 Nov; 134(5):1117-22. PubMed ID: 25248688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P, Ajzenberg N, Smahi M, Guillin MC.
    Thromb Res; 2007 Nov; 119(2):135-43. PubMed ID: 16426667
    [Abstract] [Full Text] [Related]

  • 6. A low volume specimen container suitable for monitoring the aPTT of heparinized patients.
    Ray MJ, Carroll PA, Just SJ, Hawson GA.
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):805-7. PubMed ID: 8292732
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Prescription and monitoring of anticoagulant therapies].
    Laviolle B, Oger E.
    Rev Prat; 2008 Nov 30; 58(18):2063-70. PubMed ID: 19143281
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
    Macey M, McCarthy D, Azam U, Milne T, Golledge P, Newland A.
    Cytometry B Clin Cytom; 2003 Jan 30; 51(1):30-40. PubMed ID: 12500295
    [Abstract] [Full Text] [Related]

  • 13. Monitoring heparin anticoagulation in the acute phase response.
    Uprichard J, Manning RA, Laffan MA.
    Br J Haematol; 2010 May 30; 149(4):613-9. PubMed ID: 20230412
    [Abstract] [Full Text] [Related]

  • 14. Heparin and citrate additive carryover during blood collection.
    Keppel MH, Auer S, Lippi G, von Meyer A, Cornes M, Felder TK, Oberkofler H, Mrazek C, Haschke-Becher E, Cadamuro J.
    Clin Chem Lab Med; 2019 Nov 26; 57(12):1888-1896. PubMed ID: 31377734
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ex vivo neutralization of unfractionated heparin for assessing overall haemostatic potential in patient plasma.
    Božič-Mijovski M, Vučnik M, Boc V, Blinc A, Stegnar M.
    Thromb Res; 2015 May 26; 135(5):1042-4. PubMed ID: 25805163
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.